Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Patent
1995-06-05
1998-12-22
Gupta, Yogendra N.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
514321, 514422, 540607, 546197, 548526, A61K 3155, C07D40310
Patent
active
058520082
ABSTRACT:
Compounds having the following structural formula, ##STR1## are useful for enhancing synaptic response mediated by AMPA receptors are disclosed, the invention compounds can also be used for the treatment of non-impaired subject for enhancing performance in sensory-motor and cognitive tasks which depend on brain networks utilizing AMPA receptor and for improving memory encoding.
REFERENCES:
patent: 2456991 (1948-12-01), Prill
patent: 2487179 (1949-11-01), Prill
patent: 2773062 (1956-12-01), Prill
patent: 3869431 (1975-03-01), Spiewak
patent: 3982001 (1976-09-01), Heffe et al.
patent: 4025629 (1977-05-01), Coverdale
patent: 4117228 (1978-09-01), Tanaka et al.
patent: 4209445 (1980-06-01), Oediger et al.
patent: 4209446 (1980-06-01), Schulze et al.
patent: 4209517 (1980-06-01), Riveron et al.
patent: 4333938 (1982-06-01), Creuzet et al.
patent: 4369139 (1983-01-01), Kyburz et al.
patent: 4425327 (1984-01-01), Moller et al.
patent: 4431662 (1984-02-01), Hodgson, Jr.
patent: 4438142 (1984-03-01), Vinegar
patent: 4452807 (1984-06-01), Aschwanden et al.
patent: 4499100 (1985-02-01), Kluge et al.
patent: 4535159 (1985-08-01), Forne et al.
patent: 4543361 (1985-09-01), Muchowski et al.
patent: 4548949 (1985-10-01), Muchowski et al.
patent: 4937360 (1990-06-01), Liu et al.
patent: 4948804 (1990-08-01), Galliani et al.
patent: 5196439 (1993-03-01), Sugimoto et al.
patent: 5324839 (1994-06-01), Clemence et al.
Journal of Physiology, 424, pp. 533-543, 1990.
CA 104:10668d, 1986.
Chemical Abstracts, vol. 104, No. 2, 1986, Columbus, Ohio, US; Abstract No. 10668d, p. 324; col. 2.
Chemical Abstracts, vol. 88, No. 23, 1978, Columbus, Ohio, US; Abstract No. 169713n, p. 552; col. 2.
Chemical Abstracts, vol. 58, No. 38, 1963, Columbus, Ohio, US; Abstract No. 4541d, col. 4541.
Abdulla, Riaz F., J. Heter. Chem., 10(3):347-351 (1973).
Abou-Ouf, A.A., et al., Egypt. J. Pharm. Sci., 13(I):187-194 (1972).
Baudry, D., et al., Tetrahedron Letters, 54:4707-4710 (1970).
Baudry, D., et al., Bulletin de la Societe Chimque de France, 4:1413-1415 (1971) w/English abstract, see Chemical Abstracts, 75:300 No. 48308g (1971).
Cacchi, S., et al., Tetrahedron Letters, 27(33):3931-3934 (1986).
Gourdie, T.A., et al., J. Med. Chem., 33:1177-1186 (1990).
Housny, A., et al., Polymer Prepr., 27(1):120-121 (1986).
Ritter, D., et al., Chem. Ber., 119:3704-3717 (1986).
Sam. Joseph, et al., J. Pharm. Sci., 56(6):729-731 (1967).
Schwarz, G., et al., Liebigs Ann. Chem., 1257-1270 (1981).
Tilly, G., Chimie Therapeutique, 1:57-65 (1967).
Lynch Gary S.
Rogers Gary A.
Gupta Yogendra N.
The Regents of the University of California
LandOfFree
Heteroatom substituted benzoyl derivatives that enhance synaptic does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Heteroatom substituted benzoyl derivatives that enhance synaptic, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Heteroatom substituted benzoyl derivatives that enhance synaptic will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2047836